close

Fundraisings and IPOs

1 2 3 4 68
Number of results: 1351
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-12-11 Viking Therapeutics (USA - PA) $14.8 million private placement Endocrinological diseases - Metabolic diseases Private placement
2017-12-05 Cell and Gene Therapy Catapult (UK) Oxford MEStar (UK) AK (Suzhou) Biomedical (Chinaà undisclosed grant Innovate UK-Jiangsu Industrial Challenge Programme (UK - China) Technology - Services Grant
2017-12-05 Grifols (Spain) € 85 million loan European Investment Bank (EIB) Rare diseases - Genetic diseases Loan
2017-12-04 Harmonic Pharma (France) undisclosed capital increase Novacap (France) Technology - Services Capital increase
2017-11-29 Y-mAbs Therapeutics (US - NY) $80 million private placement HBM Healthcare Investments (Switzerland), current shareholders, Sofimac Partners (France) Scopia Capital Management (US - NY) Cancer - Oncology Private placement
2017-11-17 VBL Therapeutics/Vascular Biogenics (Israel) financing round Cancer - Oncology Financing round
2017-11-15 Erytech Pharma $130 million capital increase Cancer - Oncology - Rare diseases Capital increase
2017-11-10 Transgene (France) € 14.4 million capital increase qualified U.S. and European institutional investors including Institut Mérieux (France) and Dassault Belgique Aviation Cancer - Oncology - Infectious diseases Capital increase
2017-11-06 Nouscom (Switzerland) €42 Million series B financing round Abingworth (UK) 5AM Ventures (USA - CA) LSP (The Netherlands) Versant Ventures. (USA - CA) Cancer - Oncology Series B financing round
2017-10-16 Antabio (France) € 7.3 million series A financing round iXO Private Equity (France) IRDI SORIDEC Gestion (France) Galia Gestion (France) and company’s historical investors including former President of OM Pharma Christophe Ricard. Rare diseases - Infectious diseases Series A financing round
2017-10-09 Faron Pharmaceuticals (Finland) £10.0 million private placement Cardiovascular diseases Private placement
2017-09-26 Juno Therapeutics (USA - WA) $318.7 million private placement Cancer - Oncology Private placement
2017-09-22 DaVolterra (France) € 20 million loan European Investment Bank (EIB) Infectious diseases Loan
2017-09-18 Evotec (Germany) up to € 75 million loan European Investment Bank (EIB) Technology - Services Loan
2017-09-18 Soligenix (USA - NJ) $1.5 million grant National Cancer Institute (NCI) (USA) Cancer - Oncology Grant
2017-09-13 Genenta Science (Italy) $8,4 Million (€7 Million) series B financing round Italian, British, and Swiss private investors, family offices, business angels, Banca Esperia (Italy) Mediolanum (Italy), board members Cancer - Oncology Series B financing round
2017-08-28 Apeiron Biologics (Austria) € 25 million grant European Investment Bank (EIB) Cancer - Oncology Grant
2017-08-15 Omeros (USA - Wn) private placement Private placement
2017-08-15 Dynavax (USA - CA) $80.8 million private placement Infectious diseases Private placement
2017-08-09 Spark Therapeutics (USA - PA) $380.4 million private placement Private placement